Cardiovascular effects of oral appliance treatment

Peter J. Wijkstra

Source: 5th Sleep and Breathing Conference
Number: 82

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Peter J. Wijkstra. Cardiovascular effects of oral appliance treatment. 5th Sleep and Breathing Conference

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Update on oral appliance therapy
Source: Eur Respir Rev, 28 (153) 190083; 10.1183/16000617.0083-2019
Year: 2019

Oral appliance treatment – status praesens
Source: 5th Sleep and Breathing Conference
Year: 2019

Cardiovascular adverse effects during itraconazole therapy
Source: Eur Respir J 2008; 32: 240
Year: 2008

Drug-induced sleep endoscopy predictors for oral appliance treatment outcome
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013

Oral appliances: from theory to practice. Recent data regarding compliance, efficacy and side-effects
Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives
Year: 2005

Effect of tezepelumab on exacerbation-related oral corticosteroid use in NAVIGATOR
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021

Cardiovascular safety of long-term therapy with combination bronchodilator in patients with stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment.
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Autonomic cardiac modulation response due to the use of an oral appliance to treat OSA – Pilot study
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011

Weight loss and oral appliance in the treatment of snoring patients
Source: Eur Respir J 2003; 22: Suppl. 45, 96s
Year: 2003

Clinical efficacy of oral sildenafil therapy in the treatment of pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007

Asthma and hayfever is associated with use of oral contraceptives and hormonal replacement therapy
Source: Annual Congress 2003 - Risk factors for asthma
Year: 2003

Patient-reported side effects of oral corticosteroids
Source: International Congress 2018 – Medical education via the web and the internet
Year: 2018

Osteoporosis in patients with long-term inhaled corticosteroids treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 613s
Year: 2007

Cardiovascular effects of oral appliance therapy in obstructive sleep apnea: a systematic review and meta-analysis
Source: International Congress 2017 – CPAP therapy
Year: 2017

Alternatives for OSAHS treatment: selection of patients for upper airway surgery and oral appliances
Source: Eur Respir Rev 2007; 16: 132-145
Year: 2007

One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy
Source: Eur Respir J 2004; 24: Suppl. 48, 618s
Year: 2004